🇺🇸 FDA
Patent

US 10196377

Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives

granted A61PA61P11/00A61P11/02

Quick answer

US patent 10196377 (Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives) held by OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES”
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/04, A61P31/12